— Know what they know.
Not Investment Advice

XENT NASDAQ

Intersect ENT, Inc.
1W: +1.5% 1M: +1.1% 3M: +3.1% 1Y: +57.7% 3Y: +8.2% 5Y: +21.6%
$28.24
Last traded 2022-05-12 — delisted
NASDAQ · Healthcare · Medical - Devices

📊 Key Metrics

TTM
$104M
Revenue
+22.3% YoY
$-170M
Net Income
-127.8% YoY
$-71M
Free Cash Flow
-49.4% YoY
64.4%
Gross Margin
-124.0%
Op. Margin
-143.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE816.2%
ROA-100.9%
ROIC-914.0%

Valuation

P/E-5.9
P/B-13.6
EV/EBITDA-6.6

Leverage

Debt/Equity-1.68
Current Ratio1.88
Interest Cov.-22.8x

Quality Scores

Piotroski F2/9
Altman Z-5.85
Beneish M-6.75

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms